Search

 
Start a new search





Results 1-10 of 19.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC765832012Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrestVALLON M.; SEIDL C.; BLECHERT B.; LI Zhoulei; GILBERTZ K.-P.; BAUMGART Anja; AICHLER M; FEUCHTINGER A; GAERTNER F. C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; WALCH Axel K.; SENEKOWITSCH-SCHMIDTKE R.; ESSLER M.
JRC717132012Combined 213Bi-DTPA- F3 and paclitaxel treatment of peritoneal spread of human ovarian carcinoma in a mouse model enhances therapeutic efficacy due to enhanced induction of apoptosis and G2/M phase cell-cycle arrestSEIDL C.; VALLON M.; BLECHERT B.; GILBERTZ K.-P.; AICHLER M; FEUCHTINGER A; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC755762012Radioimmunotherapy of pancreatic cancer with 213Bi-labeled antibodies to intranuclear histonesDADACHOVA E.; BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; SELLERS R.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN A
JRC717102012Synthesis and in vitro evaluation of 225Ac-DOTA-SubstanceP for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA AGNIESZKA; BRUCHERTSEIFER Frank; WEIS Mirjam; BONELLI Milton; LAURENZA M; APOSTOLIDIS Christos; MORGENSTERN Alfred
JRC755772012Alpha particles and induction of an anti-tumour immune responseGORIN J; GOUARD S.; CHEREL M.; FAIVRE-CHAUVET A; MENAGER J; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DAVODEAU F; GASCHET J
JRC701862012Bismuth-213 and Actinium-225 – Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting RadioisotopesMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos
JRC709082012Measurement of the 225Ac half-lifePOMME Stefaan; MAROULI MARIA; SULIMAN GABRIEL; DIKMEN HASAN; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN A.; STROH HEIKO; PAEPEN Jan; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MORGENSTERN Alfred
JRC701392012Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostateRIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a.
JRC702992012In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapyGRAF Franziska; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; KAINA B; SCHRECKENBERGER M; MIEDERER Matthias
JRC729012012Synthesis of 213Bi-DOTATOC for peptide receptor alpha-therapy of GEP-NET patients refractory to beta therapyMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL Clemens
Results 1-10 of 19.

Discover